Pauley Penelope, Matthews Brya G, Wang Liping, Dyment Nathaniel A, Matic Igor, Rowe David W, Kalajzic Ivo
Department of Reconstructive Sciences, MC 3705, University of Connecticut Health Center, 263 Farmington Ave., Farmington, CT, 06032, USA.
Int Orthop. 2014 Sep;38(9):1955-62. doi: 10.1007/s00264-013-2249-y. Epub 2014 Jan 3.
Osteogenesis imperfecta is a serious genetic disorder that results from improper type I collagen production. We aimed to evaluate whether bone marrow stromal cells (BMSC) delivered locally into femurs were able to engraft, differentiate into osteoblasts, and contribute to formation of normal bone matrix in the osteogenesis imperfect murine (oim) model.
Donor BMSCs from bone-specific reporter mice (Col2.3GFP) were expanded in vitro and transplanted into the femoral intramedullary cavity of oim mice. Engraftment was evaluated after four weeks.
We detected differentiation of donor BMSCs into Col2.3GFP+ osteoblasts and osteocytes in cortical and trabecular bone of transplanted oim femurs. New bone formation was detected by deposition of dynamic label in the proximity to the Col2.3GFP+ osteoblasts, and new bone showed more organized collagen structure and expression of type I α2 collagen. Col2.3GFP cells were not found in the contralateral femur indicating that transplanted osteogenic cells did not disseminate by circulation. No osteogenic engraftment was observed following intravenous transplantation of BMSCs. BMSC cultures derived from transplanted femurs showed numerous Col2.3GFP+ colonies, indicating the presence of donor progenitor cells. Secondary transplantation of cells recovered from recipient femurs and expanded in vitro also showed Col2.3GFP+ osteoblasts and osteocytes confirming the persistence of donor stem/progenitor cells.
We show that BMSCs delivered locally in oim femurs are able to engraft, differentiate into osteoblasts and osteocytes and maintain their progenitor potential in vivo. This suggests that local delivery is a promising approach for introduction of autologous MSC in which mutations have been corrected.
成骨不全是一种严重的遗传性疾病,由I型胶原蛋白产生不当所致。我们旨在评估局部注入股骨的骨髓间充质干细胞(BMSC)是否能够在成骨不全小鼠(oim)模型中植入、分化为成骨细胞并有助于形成正常骨基质。
从骨特异性报告基因小鼠(Col2.3GFP)获取的供体BMSC在体外扩增后移植到oim小鼠的股骨髓腔内。四周后评估植入情况。
我们在移植的oim股骨的皮质骨和小梁骨中检测到供体BMSC分化为Col2.3GFP+成骨细胞和骨细胞。通过在Col2.3GFP+成骨细胞附近沉积动态标记物检测到新骨形成,并且新骨显示出更有序的胶原结构和I型α2胶原的表达。在对侧股骨中未发现Col2.3GFP细胞,表明移植的成骨细胞未通过循环扩散。静脉注射BMSC后未观察到成骨植入。来自移植股骨的BMSC培养物显示出大量Col2.3GFP+集落,表明存在供体祖细胞。从受体股骨中回收并在体外扩增的细胞进行二次移植也显示出Col2.3GFP+成骨细胞和骨细胞,证实了供体干/祖细胞的持久性。
我们表明,局部注入oim股骨的BMSC能够植入、分化为成骨细胞和骨细胞并在体内维持其祖细胞潜能。这表明局部递送是引入已纠正突变的自体间充质干细胞的一种有前景的方法。